Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YJP-14 for Endothelial Dysfunction in Diabetes
NCT01836172Phase 2Unknown
- Sponsor
- Hanwha Pharma
- Start
- Apr 2013
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of YJP-14 in endothelial dysfunction, sponsored by Hanwha Pharma. Status: unknown.
02
Drugs
YJP-14
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT01836172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836172.